Insulin Receptor 1142-1153
CAS No. 141171-54-2
Insulin Receptor 1142-1153 ( [pTyr1146][pTyr1150][pTyr1151]Insulin Receptor 1142-1153 )
Catalog No. M29958 CAS No. 141171-54-2
[pTyr1146][pTyr1150][pTyr1151]Insulin Receptor (1142-1153) binds to insulin and can be used as insulin receptor tyrosine kinase substrates.
Purity : >98% (HPLC)
Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameInsulin Receptor 1142-1153
-
NoteResearch use only, not for human use.
-
Brief Description[pTyr1146][pTyr1150][pTyr1151]Insulin Receptor (1142-1153) binds to insulin and can be used as insulin receptor tyrosine kinase substrates.
-
Description[pTyr1146][pTyr1150][pTyr1151]Insulin Receptor (1142-1153) binds to insulin and can be used as insulin receptor tyrosine kinase substrates.
-
Synonyms[pTyr1146][pTyr1150][pTyr1151]Insulin Receptor 1142-1153
-
PathwayTyrosine Kinase
-
TargetInsulin Receptor
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number141171-54-2
-
Formula Weight1862.7
-
Molecular FormulaC72H110N19O33P3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Insulin degludec
Insulin degludec is an ultra-long-acting form of insulin used for the treatment of hyperglycemia caused by type 1 and type 2 dabetes. Insulin degludec shows binding efficiency with an IC50 value of 19.59 nM/L for insulin receptor. Insulin degludec can be used for the research of type 1 and type 2 diabetes.
-
[D-Ala2]-GIP (human)
Highly potent GIP receptor agonist (EC50 = 630 ± 119 pM). Displays equivalent cAMP stimulating properties and improved resistance to enzymatic degradation compared to native GIP in cells expressing wild type GIP receptor. Improves glucose tolerance, insulin release and cognitive function in various animal models of obesity and diabetes. Displays neuroprotective effects in an MPTP model of PD.
-
GIP (1-30) amide (Hu...
GIP (1-30) amide (Human) is an insulin-dependent glucose-dependent polypeptide.The sugar-dependent insulin polypeptide (GIP) is an insulin secreting hormone, which can stimulate the secretion of insulin and reduce the occurrence of postpranal-glycemic diseases.